24/March/22

 

US regulators at the Food and Drug Administration (FDA) have cleared the way for the sale of beef from gene-edited "slick-haired" cattle after the Food and Drug Administration (FDA) concluded the animals do not raise any safety concerns. However, there seem to be many problems in the genetic makeup of these cattle arising from the gene editing process, which the FDA has dismissed. And the greatest mystery is, given the wide availability of different breeds of high-performing naturally bred slick-haired cattle, why anyone bothered to develop a gene-edited version. GMWatch

 

 

A new report from CBAN and Testbiotech discusses the basic differences between plant breeding and genetic engineering. It details unintended effects caused by techniques of new genetic engineering and explains why they create a new quality of hazards and risks. Finally, it argues that new genetic engineering needs regulation. [GMW comment: This is an excellent report that deserves to be read and digested in full. It provides a comprehensive explanation of why arguments that new genetic engineering techniques only mimic what could happen in nature are false and indefensible. We expect that it will prove to be useful in many contexts, including to counter attempts by various governments to deregulate new GM on the supposed grounds of its naturalness and precision.] CBAN and Testbiotech

 

 

A St Louis judge has granted a two-week delay in a Roundup cancer trial that was slated for opening statements next week. A family emergency reportedly requires the attention of one of Monsanto’s defence attorneys. The trial is over claims brought by three men alleging exposure to Monsanto’s glyphosate-based herbicides, such as Roundup, caused them to develop non-Hodgkin lymphoma. UnSpun